Literature DB >> 21785211

Oxidized CaMKII: a "heart stopper" for the sinus node?

Sabine Huke, Björn C Knollmann.   

Abstract

Each normal heart beat is triggered by an electrical impulse emitted from a group of specialized cardiomyocytes that together form the sinoatrial node (SAN). In this issue of the JCI, Swaminathan and colleagues demonstrate a new molecular mechanism that can disrupt the normal beating of the heart: angiotensin II - typically found in increased levels in heart failure and hypertension - oxidizes and activates Ca2+/calmodulin-dependent kinase II via NADPH oxidase activation, causing SAN cell death. The loss of SAN cells produces an electrical imbalance termed the "source-sink mismatch," which may contribute to the SAN dysfunction that affects millions of people later in life and complicates a number of heart diseases.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21785211      PMCID: PMC3148748          DOI: 10.1172/JCI58389

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  18 in total

1.  Pathological studies in sinoatrial disorder (sick sinus syndrome).

Authors:  R Evans; D B Shaw
Journal:  Br Heart J       Date:  1977-07

2.  A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure.

Authors:  J N Cohn; G Johnson; S Ziesche; F Cobb; G Francis; F Tristani; R Smith; W B Dunkman; H Loeb; M Wong
Journal:  N Engl J Med       Date:  1991-08-01       Impact factor: 91.245

3.  Calmodulin-dependent protein kinase II mediates signal transduction in apoptosis.

Authors:  S C Wright; U Schellenberger; L Ji; H Wang; J W Larrick
Journal:  FASEB J       Date:  1997-09       Impact factor: 5.191

4.  Oxidized CaMKII causes cardiac sinus node dysfunction in mice.

Authors:  Paari Dominic Swaminathan; Anil Purohit; Siddarth Soni; Niels Voigt; Madhu V Singh; Alexey V Glukhov; Zhan Gao; B Julie He; Elizabeth D Luczak; Mei-ling A Joiner; William Kutschke; Jinying Yang; J Kevin Donahue; Robert M Weiss; Isabella M Grumbach; Masahiro Ogawa; Peng-Sheng Chen; Igor Efimov; Dobromir Dobrev; Peter J Mohler; Thomas J Hund; Mark E Anderson
Journal:  J Clin Invest       Date:  2011-07-25       Impact factor: 14.808

5.  Calmodulin kinase II inhibition protects against myocardial cell apoptosis in vivo.

Authors:  Yingbo Yang; Wei-Zhong Zhu; Mei-ling Joiner; Rong Zhang; Carmine V Oddis; Yue Hou; Jinying Yang; Edward E Price; Linda Gleaves; Mesut Eren; Gemin Ni; Douglas E Vaughan; Rui-Ping Xiao; Mark E Anderson
Journal:  Am J Physiol Heart Circ Physiol       Date:  2006-07-21       Impact factor: 4.733

Review 6.  Redox regulation of cardiac calcium channels and transporters.

Authors:  Aleksey V Zima; Lothar A Blatter
Journal:  Cardiovasc Res       Date:  2006-03-06       Impact factor: 10.787

7.  A dynamic pathway for calcium-independent activation of CaMKII by methionine oxidation.

Authors:  Jeffrey R Erickson; Mei-ling A Joiner; Xiaoqun Guan; William Kutschke; Jinying Yang; Carmine V Oddis; Ryan K Bartlett; John S Lowe; Susan E O'Donnell; Nukhet Aykin-Burns; Matthew C Zimmerman; Kathy Zimmerman; Amy-Joan L Ham; Robert M Weiss; Douglas R Spitz; Madeline A Shea; Roger J Colbran; Peter J Mohler; Mark E Anderson
Journal:  Cell       Date:  2008-05-02       Impact factor: 41.582

8.  Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators.

Authors:  M A Pfeffer; E Braunwald; L A Moyé; L Basta; E J Brown; T E Cuddy; B R Davis; E M Geltman; S Goldman; G C Flaker
Journal:  N Engl J Med       Date:  1992-09-03       Impact factor: 91.245

9.  Angiotensin II-induced oxidative stress resets the Ca2+ dependence of Ca2+-calmodulin protein kinase II and promotes a death pathway conserved across different species.

Authors:  Julieta Palomeque; Omar Velez Rueda; Luciana Sapia; Carlos A Valverde; Margarita Salas; Martin Vila Petroff; Alicia Mattiazzi
Journal:  Circ Res       Date:  2009-10-22       Impact factor: 17.367

10.  Charting calcium-regulated apoptosis pathways using chemical biology: role of calmodulin kinase II.

Authors:  Maria Hägg Olofsson; Aleksandra Mandic Havelka; Slavica Brnjic; Maria C Shoshan; Stig Linder
Journal:  BMC Chem Biol       Date:  2008-08-01
View more
  7 in total

Review 1.  Sinus node dysfunction in catecholaminergic polymorphic ventricular tachycardia: risk factor and potential therapeutic target?

Authors:  Michela Faggioni; Christian van der Werf; Bjorn C Knollmann
Journal:  Trends Cardiovasc Med       Date:  2014-07-10       Impact factor: 6.677

Review 2.  Molecular and tissue mechanisms of catecholaminergic polymorphic ventricular tachycardia.

Authors:  Matthew J Wleklinski; Prince J Kannankeril; Bjӧrn C Knollmann
Journal:  J Physiol       Date:  2020-04-27       Impact factor: 5.182

Review 3.  Function and dysfunction of human sinoatrial node.

Authors:  Boyoung Joung; Peng-Sheng Chen
Journal:  Korean Circ J       Date:  2015-05-27       Impact factor: 3.243

Review 4.  CaMKII in sinoatrial node physiology and dysfunction.

Authors:  Yuejin Wu; Mark E Anderson
Journal:  Front Pharmacol       Date:  2014-03-18       Impact factor: 5.810

Review 5.  Mitochondrial Dysfunction-Associated Arrhythmogenic Substrates in Diabetes Mellitus.

Authors:  Jiajia Song; Ruilin Yang; Jing Yang; Lufang Zhou
Journal:  Front Physiol       Date:  2018-12-06       Impact factor: 4.566

Review 6.  Targeting Ca2 + Handling Proteins for the Treatment of Heart Failure and Arrhythmias.

Authors:  Alexandra Njegic; Claire Wilson; Elizabeth J Cartwright
Journal:  Front Physiol       Date:  2020-09-04       Impact factor: 4.566

7.  Mitochondrial-Mediated Oxidative Ca2+/Calmodulin-Dependent Kinase II Activation Induces Early Afterdepolarizations in Guinea Pig Cardiomyocytes: An In Silico Study.

Authors:  Ruilin Yang; Patrick Ernst; Jiajia Song; Xiaoguang M Liu; Sabine Huke; Shuxin Wang; Jianyi Jay Zhang; Lufang Zhou
Journal:  J Am Heart Assoc       Date:  2018-08-07       Impact factor: 5.501

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.